![Robert Georgantas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Georgantas
President at
Providence Therapeutics, Inc.
Profile
Robert W.
Georgantas is currently the President & Chief Technology Officer at Providence Therapeutics, Inc. Prior to this, he was the Senior VP-Research & Translational Science at Biodesix, Inc. He holds a doctorate degree from The Johns Hopkins University School of Medicine.
Robert Georgantas active positions
| Companies | Position | Start |
|---|---|---|
Providence Therapeutics, Inc.
 Providence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | President | 2023-01-31 |
Former positions of Robert Georgantas
| Companies | Position | End |
|---|---|---|
| BIODESIX, INC. | Corporate Officer/Principal | 2023-01-31 |
Training of Robert Georgantas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Biodesix, Inc.
 Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence Therapeutics, Inc.
Providence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | Health Technology |
- Stock Market
- Insiders
- Robert Georgantas
